Ables 2000.
Methods | Multicentre, randomized, parallel‐group study Duration of the study: October 1994 to December 1996 Patients excluded/patients randomized: 6/125 (5%) Sample size calculation/method description: No/No |
|
Participants |
Patients randomized: 125 Age (mean): 46 years (treatment group), 42 years (placebo group) Sex: 82 men, 37 women Inclusion criteria: trauma or surgical patients, expected length of stay > 48 hours, > 1 risk factors (e.g. central venous line, total parenteral nutrition, mechanical ventilation, antibiotics administration, etc.) Exclusion criteria: unexpected serious adverse reaction to azole drugs, thrombocytopenia (< 5000/mm3), leucopenia (< 4000/mm3), increasing liver function tests greater than five times the upper limits of normal, pregnancy, anticipated life expectancy of less than three months, severe liver disease, current treatment with a systemic antifungal agent Percentage post‐surgical: > 30% Percentage colonized with Candida at baseline: 24% |
|
Interventions |
1. Fluconazole 800 mg/day IV initially then 400 mg/day IV or orally (n = 63)
2. Placebo (n = 62) Duration of the intervention: until ICU discharge |
|
Outcomes | Mortality
Proven IFI
Suspected IFI Proven or suspected IFI Proven IFI with azole‐resistant species Superficial FI Fungal colonization Fungal colonization with azole‐resistant species Adverse events requiring cessation Follow‐up duration: until hospital discharge |
|
Type of antifungal treatment | Prophylaxis | |
Funding sources | Quote: "This study was supported by an investigator‐initiated grant from Roerig/Pfizer" | |
Declaration of interest among the primary researchers | Not reported | |
Notes | Country: USA Setting: single hospital, adult ICU | |
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Random sequence generation (selection bias) | Unclear risk | Quote: “Patients meeting the eligibility criteria were randomly assigned to receive one of the following two prophylaxis regimen…” Comment: insufficient information to make a judgement |
Allocation concealment (selection bias) | Unclear risk | Comment: insufficient information to make a judgement |
Blinding of participants and personnel (performance bias) All outcomes | Unclear risk | Comment: insufficient information to make a judgement |
Blinding of outcome assessment (detection bias) All outcomes | Unclear risk | Comment: insufficient information to make a judgement |
Incomplete outcome data (attrition bias) All outcomes | Low risk | Comment: missing outcome data balanced in numbers across groups, and reasons for missing outcome data unlikely to be related to true outcome |
Selective reporting (reporting bias) | Low risk | Comment: the study protocol was not available, but it was clear that the published report included all expected outcomes |
Other bias | Low risk | The study appeared free of other sources of bias |